Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Confirmed responses observed in eight tumor types spanning ovarian, lung, breast, endometrial, head and neck, colorectal, gallbladder, and ampullary carcinoma34% overall response rate (ORR) observed among 103 evaluable patients across all cohorts with a median duration of response of 7.6 months46% ORR observed among 48 evaluable patients in ovarian cancer cohort with a me ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) breached their fiduciary duties to shareholders. If you currently own BioXcel stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about. ...

The move could help the payment product's big bank owners head off cryptocurrency competition. ...

Core Insights - JPMorgan is entering the crypto-backed lending market, allowing customers to borrow against Bitcoin and Ether by the end of the year [2][7] - This move threatens crypto-native lenders who have relied on digital asset collateral as a key differentiator [3][5] - Crypto banks are innovating to differentiate themselves, with offerings beyond just Bitcoin and Ether [6][8] Group 1: JPMorgan's Strategy - JPMorgan began its crypto-backed lending initiative by allowing wealthy clients to use crypto ETF shares as collateral [2] - The bank's entry into the market is expected to bring competitive interest rates, potentially attracting clients from existing crypto lenders [4][5] Group 2: Impact on Crypto-Native Lenders - The acceptance of digital assets as collateral by JPMorgan could disrupt the business models of niche lenders like AMINA and Sygnum [3][6] - Crypto-native lenders are responding by developing new products and services, such as multi-signature lending solutions [8] Group 3: Market Dynamics - Typical interest rates for crypto-backed loans range from 10% to 15% APR, which are higher than traditional credit sources [4] - The increased competition from JPMorgan may force crypto-native lenders to innovate further to retain their client base [7]

Core Viewpoint - Regional banks have faced significant challenges, including poor loan performance and fraud allegations, but recent Q3 earnings reports show signs of resilience and potential recovery in the sector [1][2][4]. Group 1: Market Sentiment and Challenges - Investors have been concerned about the banking sector due to fraud allegations and bankruptcies at subprime lenders, which have heightened fears of contagion among regional banks [2][3]. - The regional banking sector has lagged behind the broader market for most of 2025, but recent earnings successes may indicate a turning point [5]. - Factors contributing to market anxiety include significant exposure to troubled companies and the potential for further financial fallout [3][4]. Group 2: Company Performance Highlights - U.S. Bancorp reported record revenue in Q3, exceeding both top and bottom line estimates, with net interest income (NII) increasing over 2% year-over-year and non-interest income growing nearly 10% [6][7][8]. - PNC Financial Services Group also announced better-than-expected earnings for Q3, with a 7% year-over-year increase in NII and a reduction in credit losses from $243 million to $167 million [10][11][12]. - Capital One Financial demonstrated strong performance with a 23% revenue growth from the previous quarter, NII of approximately $12.4 billion, and interest margins expanding to 8.3% [15][16][17]. Group 3: Regulatory and Economic Concerns - The commercial real estate (CRE) sector remains a primary concern, with an estimated $1 trillion in CRE loans due by the end of the year, complicating refinancing efforts for regional banks [6]. - Regulatory uncertainty persists, with potential changes in capital requirements and stress tests that could impact smaller banks [6]. - A recent fraud-related lawsuit against Western Alliance Bancorp has added to the sector's volatility, reflecting the ongoing challenges faced by regional banks [6].

Core Insights - Synopsys (SNPS) and Marvell Technology (MRVL) are key players in the AI Cluster and Data Center interconnect market, with the market projected to grow from $15.38 billion in 2025 to $25.89 billion in 2030, reflecting a CAGR of 11% [1][2]. Synopsys (SNPS) Overview - Synopsys is actively capturing the AI cluster interconnect market through product launches such as Ultra Accelerator Link and Ultra Ethernet IP solutions, with UALink offering a throughput of 200 Gbps per lane [3][4]. - The Ultra Ethernet IP is designed to help customers build AI scale-out networks, maximizing bandwidth at data rates up to 1.6 terabytes per second [4][5]. - Despite its strong product offerings, SNPS faces competitive pressure from companies like Broadcom and Marvell Technology, which can vertically integrate their chips and networks [6]. - SNPS' Design IP business experienced an 8% year-over-year decline, impacting both revenue and earnings, with a Zacks Consensus Estimate for fiscal 2025 earnings at $12.8 billion, a decline of 2.8% year-over-year [6][7]. Marvell Technology (MRVL) Overview - Marvell Technology is well-established in the data center connectivity market, with products like Active Copper Cable Linear Equalizers and COLORZ 800G ZR/ZR+ for Multi-Site AI Training, which supports scalable transmission up to 2,000 km [9][11]. - The enterprise networking segment saw a 28% year-over-year revenue increase to $194 million, while carrier infrastructure grew 71% to $130 million in the second quarter of fiscal 2026 [12]. - MRVL expects third-quarter revenues to be around $2.06 billion, indicating a year-over-year growth of 35.9%, with fiscal 2026 and 2027 earnings expected to grow by 78.3% and 19.2%, respectively [13]. Stock Performance and Valuation - Year-to-date, Marvell Technology shares have decreased by 25.1%, while Synopsys stock has lost 6% [14]. - MRVL is trading at a forward sales multiple of 7.88X, above its median of 7.40X, while SNPS' forward sales multiple is at 8.76X, below its median of 11.04X [16]. Conclusion - While both companies are positioned to benefit from the data center interconnect market, SNPS faces challenges such as a decline in its Design IP business and increased competition, making MRVL a more attractive investment option at present [17][18].

Key Takeaways Xylem is set to report Q3 results on Oct 28, with revenues estimated at $2.22 billion, up 5.7% year over year.Water Infrastructure and smart metering demand are likely to support segmental performance.High material and labor costs, plus integration expenses, may pressure XYL's margins this quarter.Xylem Inc. (XYL) is scheduled to release third-quarter 2025 results on Oct. 28, before market open.The Zacks Consensus Estimate for XYL’s third-quarter revenues is pegged at $2.22 billion, indicating ...

Key Takeaways Biogen is set to report Q3 2025 results on Oct. 30, with expectations for another earnings beat.Lower MS drug sales are likely to be offset by gains from Skyclarys, Zurzuvae, and Alzheimer's drug Leqembi.Sales of the spinal muscular atrophy drug, Spinraza, are likely to have declined due to lower demand. We expect Biogen (BIIB) to beat expectations when it reports third-quarter 2025 results on Oct. 30, before market open. In the last reported quarter, the company's earnings beat expectations b ...

Key Takeaways Enterprise Products Partners will announce third-quarter 2025 earnings on Oct. 30.EPD's estimated EPS of 67 cents suggests 3.1% growth, while revenue may fall 7.9% year over year.Natural Gas Pipelines & Services margin is projected to rise to $402.33M from $349M a year earlier.Enterprise Products Partners LP (EPD) is set to report third-quarter 2025 results on Oct. 30, before the opening bell.In the last reported quarter, its adjusted earnings of 66 cents per unit beat the Zacks Consensus Esti ...